30/05/2016 - 21:34

MGC Pharma to enter Canadian market with cannabis cosmetics

30/05/2016 - 21:34

Bookmark

Upgrade your subscription to use this feature.

The dominos are starting to fall for ASX listed Medical Cannabis upstart MGC Pharma, with its third regulatory approval in 3 months being granted. The company will now have the right to market its unique medical cannabis based cosmetic line known as “MGC Derma” into the $1.9b a year Canadian market after the Canadian regulatory authority, Health Canada approved the product.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options